The test distinguishes between SARS-CoV-2, Influenza A, and Influenza B with a single nasal swab, providing rapid and accurate results in just 10 minutes. This makes it an essential tool for maintaining a safe and healthy environment.

Our collaboration with DCN Dx, a leading contract research organization for in vitro diagnostics, through the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program ensures the highest level of quality, accuracy, and reliability in our tests.